Evidence map›Paper›PMID 37047306›Full record

ReviewInternational journal of molecular sciences2023

Specialized Ribosomes in Health and Disease.

Sarah C Miller, Clinton C MacDonald, Morgana K Kellogg, Zemfira N Karamysheva, Andrey L Karamyshev

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. RiboScreenBiomedicines · 2026
    Review
  5. Article
  6. Review
  7. The ribosomal landscape in influenza A virus infection: from molecular mechanisms to clinical relevance.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Building a case for 'functional identity fraud' in eRpL22 paralogue-specific ribosomes inPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  14. Review
  15. The Interplay Between theInternational journal of molecular sciences · 2024
    Review
  16. Review
  17. RiboScreenInternational journal of molecular sciences · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sarah C MillerDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0009-0006-0730-6506
Clinton C MacDonaldDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0003-3209-1982
Morgana K KelloggDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0003-2286-235X
Zemfira N KaramyshevaDepartment of Biological Sciences, Texas Tech University, Lubbock, TX 79409, USA.ORCID 0000-0002-1589-0216
Andrey L KaramyshevDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0001-9645-1655
Texas Tech University · US

Funding

Regulation of Aberrant Protein ProductionR01GM135167 · NIGMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI KARAMYSHEV, ANDREY L · 2019 to 2022
$1.3M
Ribosome remodeling as a mechanism of translational control during stressR15GM146171 · NIGMS · TEXAS TECH UNIVERSITY · PI SALAZAR-BRAVO, JORGE · 2022 to 2023
$559k
NIGMS NIH HHS R01 GM135167NIGMS NIH HHS R01GM135167NIGMS NIH HHS R15 GM146171NIGMS NIH HHS R15GM146171
6 · The paper itself

Abstract

Ribosomal heterogeneity exists within cells and between different cell types, at specific developmental stages, and occurs in response to environmental stimuli. Mounting evidence supports the existence of specialized ribosomes, or specific changes to the ribosome that regulate the translation of a specific group of transcripts. These alterations have been shown to affect the affinity of ribosomes for certain mRNAs or change the cotranslational folding of nascent polypeptides at the exit tunnel. The identification of specialized ribosomes requires evidence of the incorporation of different ribosomal proteins or of modifications to rRNA and/or protein that lead(s) to physiologically relevant changes in translation. In this review, we summarize ribosomal heterogeneity and specialization in mammals and discuss their relevance to several human diseases.

Indexed as

Protein BiosynthesisRibosomesAnimalsHumansMammalsPeptidesRibosomal ProteinsRNA, RibosomalPeptidesRibosomal ProteinsRNA, Ribosomalhuman diseaseprotein synthesisribosomal proteinribosomal RNAribosome heterogeneityribosome specializationtranslationtranslational control

Identifiers

PMID37047306
PMCPMC10093926
OpenAlexW4361225311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.